SDCCAG8 Antikörper (C-Term)
Kurzübersicht für SDCCAG8 Antikörper (C-Term) (ABIN7185251)
Target
Alle SDCCAG8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human NY-CO-8.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC:1:100-1:300, ELISA:1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SDCCAG8 (serologically Defined Colon Cancer Antigen 8 (SDCCAG8))
-
Andere Bezeichnung
- SDCCAG8
-
Hintergrund
- Antigen NY CO 8 antibody, Antigen NY-CO-8 antibody, BBS16 antibody, CCCAP antibody, CCCAP SLSN7 antibody, Centrosomal colon cancer autoantigen protein antibody, hCCCAP antibody, HSPC085 antibody, NPHP10 antibody, NPHP10 gene antibody, NY-CO-8 antibody, Sdccag8 antibody, SDCG8_HUMAN antibody, Serologically defined colon cancer antigen 8 antibody, Serologically defined colon cancer antigen 8 homolog antibody, SLSN7 antibody, SLSN7 gene antibody
-
UniProt
- Q86SQ7
-
Pathways
- M Phase, Tube Formation
Target
-